Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Abbott Laboratories    ABT

ABBOTT LABORATORIES (ABT)
Mes dernières consult.
Most popular
  Report  
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets
The feature you requested does not exist. However, we suggest the following feature:

Abbott Laboratories : DECLARES 377TH CONSECUTIVE QUARTERLY DIVIDEND

share with twitter share with LinkedIn share with facebook
share via e-mail
0
02/20/2018 | 04:44pm CET

ABBOTT PARK - The board of directors of Abbott (NYSE: ABT) today declared a quarterly common dividend of 28 cents per share.

This marks the 377th consecutive quarterly dividend to be paid by Abbott since 1924. The cash dividend is payable May 15, 2018, to shareholders of record at the close of business on April 13, 2018.

Abbott has increased its dividend payout for 46 consecutive years and is a member of the S&P 500 Dividend Aristocrats Index, which tracks companies that have increased dividends annually for at least 25 consecutive years.

About Abbott

Abbott is a global healthcare company devoted to improving life through the development of products and technologies that span the breadth of healthcare. With a portfolio of leading, science-based offerings in diagnostics, medical devices, nutritionals and branded generic pharmaceuticals, Abbott serves people in more than 150 countries and employs approximately 99,000 people.

Contact:

Tel: 224-668-0791

(C) 2018 Electronic News Publishing, source ENP Newswire

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on ABBOTT LABORATORIES
02/20ABBOTT LABORATORIES : Declares 377th consecutive quarterly dividend
AQ
02/19ABBOTT LABORATORIES PAKISTAN : Board of directors meeting of Abbott Laboratories..
AQ
02/16ABBOTT : Declares 377th Consecutive Quarterly Dividend
PR
02/15ABBOTT LABORATORIES : ' Trademark Application for "DRAGONFLY OPSTAR" Filed
AQ
02/15ABBOTT LABORATORIES : ' Trademark Application for "WHISPER" Filed
AQ
02/15ABBOTT LABORATORIES : Trademark Application for "READIFLEX" Filed by Abbott Labo..
AQ
02/15ABBOTT LABORATORIES : ' Trademark Application for "PEDIALYTE ADVANCEDCARE" Filed
AQ
02/13LIFE SCIENCE REAGENT MARKET VALUE SH : Life Science Reagent Market Overview & In..
AQ
02/09BODY SENSOR MARKET PROFESSIONAL SURV : The report segments the body sensor marke..
AQ
02/08ABBOTT LABORATORIES : Trademark Application for "ST. JUDE MEDICAL" Filed by Abbo..
AQ
More news
News from SeekingAlpha
02/21Dividend Companies Showering Shareholders With More Cash 
02/16Abbott Laboratories declares $0.28 dividend 
02/16Tracking Prem Watsa's Fairfax Financial Holdings Portfolio - Q4 2017 Update 
02/15THE DIVIDEND GROWTH PORTFOLIO TO GRO : Getting Up When Life Knocks You Down 
02/14Repairing The Foundations Of The Dividend House And Millennial Millions DGI P.. 
Financials ($)
Sales 2018 30 847 M
EBIT 2018 6 456 M
Net income 2018 3 041 M
Debt 2018 15 102 M
Yield 2018 1,86%
P/E ratio 2018 39,00
P/E ratio 2019 32,23
EV / Sales 2018 3,88x
EV / Sales 2019 3,56x
Capitalization 105 B
Chart ABBOTT LABORATORIES
Duration : Period :
Abbott Laboratories Technical Analysis Chart | ABT | US0028241000 | 4-Traders
Technical analysis trends ABBOTT LABORATORIES
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 20
Average target price 68,2 $
Spread / Average Target 13%
EPS Revisions
Managers
NameTitle
Miles D. White Chairman & Chief Executive Officer
Brian B. Yoor Chief Financial Officer & Executive VP-Finance
Randel W. Woodgrift VP-Abbott Medical Devices Cardiovascular
Roxanne Schuh Austin Independent Director
Jim Farrell Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
ABBOTT LABORATORIES2.12%104 732
JOHNSON & JOHNSON-7.19%357 710
NOVARTIS-3.37%226 667
PFIZER-2.84%216 135
ROCHE HOLDING LTD.-9.37%207 826
MERCK AND COMPANY-0.50%153 359